Skip to main content

Paul Wagner

CEO

Forte Biosciences, Inc.

Board Member

Forte Biosciences, Inc.

Equibles does not estimate personal net worth.

About Paul Wagner

Paul Wagner is recorded as Board Member at Forte Biosciences, Inc. since January 1, 2020 and CEO at Forte Biosciences, Inc.. The newest filing on record that lists Paul Wagner as CEO and Board Member at Forte Biosciences, Inc. is dated April 29, 2026. The proxy statement of Forte Biosciences, Inc. reports total compensation of $7,358,587 for Paul Wagner in fiscal 2025, including a base salary of $670,051. Disclosed compensation is on record for 7 fiscal years. Paul Wagner has spoken on 1 earnings call across 1 company, most recently for Forte Biosciences, Inc. on May 10, 2021. Forte Biosciences, Inc. is classified in the Biotechnology industry within the Healthcare sector.

Paul Wagner on recent calls

“We're going to keep today's call fairly short but I wanted to give investors an opportunity to ask any questions that you may have.”
CEO, Forte Biosciences, Inc. Q1 FY2021 Earnings Call ·

Affiliation history

  • Forte Biosciences, Inc.

    Board Member

    Proxy statement

    Current

    2020-01-01–present

    Last confirmed April 29, 2026

  • Forte Biosciences, Inc.

    CEO

    Proxy statement

    Current

    Start not stated–present

    Last confirmed April 29, 2026

Company network

Forte Biosciences, Inc.

Current role

Biotechnology · Healthcare

CEO, Board Member

2020-01-01–present

1 appearance Latest appearance 2021-05-10

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Forte Biosciences, Inc. $670,051 $7,358,587
2024 Forte Biosciences, Inc. $644,280 $1,674,458
2023 Forte Biosciences, Inc. $619,500 $1,450,175
2022 Forte Biosciences, Inc. $590,000 $1,227,610
2021 Forte Biosciences, Inc. $590,000 $5,415,196
2020 Forte Biosciences, Inc. $452,917 $776,917
2019 Forte Biosciences, Inc. $350,000 $525,000

Recent activity

  • Earnings call

    Forte Biosciences, Inc. Q1 FY2021 Earnings Call

    Forte Biosciences, Inc.